This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech medical study

Morning Coffee Lowers Mortality Risk

Analysis based on 9 articles · First reported Jan 08, 2025 · Last updated Jan 08, 2025

Sentiment
20
Attention
2
Articles
9
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The study's findings, led by researchers from Tulane University and published in the European Heart Journal, could influence consumer behavior regarding coffee consumption, potentially impacting the Food and Beverage industry. While not directly affecting stock prices, it provides valuable health information that could shape future dietary recommendations.

Food and Beverage Healthcare

A study led by researchers from Tulane University, including Lu Qi, and published in the European Heart Journal, found that drinking coffee in the morning is associated with a 16% lower risk of all-cause mortality and a 31% lower risk of death from heart disease compared to non-coffee drinkers. This benefit was not observed in individuals who drank coffee throughout the day. The research, which tracked over 40,000 adults in the United States for nearly a decade, suggests that the timing of coffee consumption, not just the amount, is crucial for health outcomes. Professor Thomas Lüscher from Royal Brompton and Harefield Hospitals provided an accompanying editorial, supporting the findings and suggesting that afternoon or evening coffee might disrupt circadian rhythms and hormone levels like melatonin, affecting cardiovascular risk factors.

per
Lu Qi, a lead author from Tulane University, spearheaded the study on coffee timing and health outcomes, suggesting a significant impact on cardiovascular health.
Importance 90.0 Sentiment 20.0
per
Thomas Lüscher, from Royal Brompton and Harefield Hospitals, provided an accompanying editorial, supporting the study's findings on the health benefits of morning coffee.
Importance 50.0 Sentiment 10.0
oth
Thomas Lüscher, a consultant cardiologist from Royal Brompton and Harefield Hospitals, contributed an editorial to the study, reinforcing its conclusions.
Importance 40.0 Sentiment 10.0
cnt
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.